To determine whether protein expression levels of CNPY3 and GRP94 are consistent with gene expression levels and associated with clinical features in human breast cancers, we used the tissue microarray (TMA) approach, which included breast cancer, their corresponding adjacent normal tissue (ANT), and metastasis tissue (n = 158). This evidence concerns the gene CNPY3 and breast cancer.